Published in Health Business Week, March 26th, 2004
"Our goal was to evaluate FDG-PET imaging in staging patients with biliary tract cancers. Fifty consecutive patients who underwent FDG-PET for suspected cholangiocarcinoma (n=36) or gallbladder carcinoma (n=14) were reviewed," investigators in the United States report.
"Patients with cholangiocarcinoma were divided into two groups: group 1 had nodular type (mass > 1 cm) (n=22) and group 2 had infiltrating type (n=14) cholangiocarcinoma. Thirty-one of 36 patients evaluated for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week